We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

86 hedge funds and large institutions have $170M invested in VanEck Biotech ETF in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

9% more funds holding

Funds holding: 79 → 86 (+7)

6% more capital invested

Capital invested by funds: $161M → $170M (+$9.23M)

3.18% more ownership

Funds ownership: 26.4% → 29.58% (+3.2%)

7% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 27

82% less call options, than puts

Call options by funds: $1.78M | Put options by funds: $10.1M

Holders
86
Holders Change
+7
Holders Change %
+8.86%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
25
Reduced
27
Closed
7
Calls
$1.78M
Puts
$10.1M
Net Calls
-$8.33M
Net Calls Change
-$13.3M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$6.24M
2
CG
Colony Group
Massachusetts
+$4.85M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.56M
4
Bank of America
Bank of America
North Carolina
+$2.45M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.89M
2
TH
Timber Hill
Connecticut
-$2.25M
3
BPC
Banque Pictet & Cie
Switzerland
-$1.77M
4
Millennium Management
Millennium Management
New York
-$1.29M
5
Jane Street
Jane Street
New York
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$964K +$975K +8,963 New
Capital Fund Management (CFM)
27
Capital Fund Management (CFM)
France
$947K +$957K +8,800 New
Janney Montgomery Scott
28
Janney Montgomery Scott
Pennsylvania
$928K +$938K +8,625 New
TBA
29
Train Babcock Advisors
New York
$893K +$605K +5,567 +204%
JP Morgan Chase
30
JP Morgan Chase
New York
$793K -$167K -1,535 -17%
RT
31
Rockland Trust
Massachusetts
$776K +$785K +7,216 New
WJA
32
Williams Jones & Associates
New York
$739K -$49.5K -455 -6%
TH
33
Timber Hill
Connecticut
$714K -$2.25M -20,720 -76%
ClearBridge Investments
34
ClearBridge Investments
New York
$688K +$334K +3,075 +92%
RJA
35
Raymond James & Associates
Florida
$673K +$123K +1,127 +22%
GJIC
36
Gamble Jones Investment Counsel
California
$645K – – –
MFS
37
MSI Financial Services
Massachusetts
$643K -$17.8K -164 -3%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$591K +$109K +1,001 +22%
LTFS
39
Ladenburg Thalmann Financial Services
Florida
$528K -$106K -974 -17%
OSNBOA
40
Old Second National Bank of Aurora
Illinois
$517K +$435K +4,004 +501%
PAG
41
Private Advisor Group
New Jersey
$507K +$201K +1,845 +70%
VKH
42
Virtu KCG Holdings
New York
$471K +$477K +4,383 New
IA
43
IFP Advisors
Florida
$402K -$116K -1,062 -22%
IAMOG
44
Investors Asset Management of Georgia
Georgia
$398K – – –
CAN
45
Cetera Advisor Networks
California
$382K +$386K +3,550 New
TRCT
46
Tower Research Capital (TRC)
New York
$372K -$25.7K -236 -6%
VWA
47
V Wealth Advisors
Kansas
$372K +$369K +3,397 New
PCMM
48
Private Capital Management (Minnesota)
Minnesota
$355K +$43.5K +400 +14%
AB
49
Atlas Brown
Kentucky
$335K – – –
RJFSA
50
Raymond James Financial Services Advisors
Florida
$330K -$49.1K -451 -13%
1
2
3 4

BBH Hedge Fund Activity: Q4 2016 in Review

86 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2016, worth a combined $170M — up 5.7% from $161M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BBH positions and 7 closed out — a net gain of 10 holders — while 25 added to existing stakes and 27 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $6.24M. The largest seller was Goldman Sachs, cutting an estimated $4.89M.

  • 86 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2016, up from 79 in Q3 2016.
  • Funds reported $170M of VanEck Biotech ETF stock for Q4 2016, up 5.7% quarter-over-quarter.
  • 17 funds opened new VanEck Biotech ETF positions in Q4 2016 and 7 closed out, a net change of +10 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2016 was AllianceBernstein, an estimated $6.24M added.
  • The largest VanEck Biotech ETF seller in Q4 2016 was Goldman Sachs, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2016.